Fibrosis ceiling may reflect treatment duration, not the number of receptors engaged: correspondence to “Engineered nutrient-stimulated hormonal multi-agonists for precision targeting of obesity and metabolic disorders”
Clinical and Molecular Hepatology · 29.10.2026
DOI: 10.3350/cmh.2026.1147 ↗Kurz gefasst
Kommentar in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 29.10.2026. Verfasst von Yun Kyung Cho und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Asan Diabetes Center, Asan Medical Center, Seoul, Republic of Korea.
- Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. chjung0204@gmail.com.
- Asan Diabetes Center, Asan Medical Center, Seoul, Republic of Korea. chjung0204@gmail.com.
Zitieren
APA
Cho, Y. K., & Jung, C. H. (2026). Fibrosis ceiling may reflect treatment duration, not the number of receptors engaged: correspondence to “Engineered nutrient-stimulated hormonal multi-agonists for precision targeting of obesity and metabolic disorders”. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.1147
Vancouver
Cho YK, Jung CH. Fibrosis ceiling may reflect treatment duration, not the number of receptors engaged: correspondence to “Engineered nutrient-stimulated hormonal multi-agonists for precision targeting of obesity and metabolic disorders”. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.1147
BibTeX
@article{Cho2026,
author = {Cho, Yun Kyung and Jung, Chang Hee},
title = {Fibrosis ceiling may reflect treatment duration, not the number of receptors engaged: correspondence to “Engineered nutrient-stimulated hormonal multi-agonists for precision targeting of obesity and metabolic disorders”},
journal = {Clinical and Molecular Hepatology},
year = {2026},
doi = {10.3350/cmh.2026.1147}
}
EUVIMED